The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Payne fell last month from his room's balcony on the third floor of his hotel in an upscale neighborhood of Argentina's ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...

Canada and its community successfully raised $20,000 in September for their partnership with Augie’s Quest, an organization seeking a cure for ALS (Amyotrophic Lateral Sclerosis) through funding ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which neurons in the central nervous system that help ...